{"id":"https://openalex.org/W4281908586","doi":"https://doi.org/10.1093/oncolo/oyac107","title":"Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan","display_name":"Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281908586","doi":"https://doi.org/10.1093/oncolo/oyac107","pmid":"https://pubmed.ncbi.nlm.nih.gov/35642907","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9355822"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyac107","doi":"https://doi.org/10.1093/oncolo/oyac107","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyac107","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/8/637/45293643/oyac107.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/article-pdf/27/8/637/45293643/oyac107.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University , Boston, MA , USA"],"raw_orcid":"https://orcid.org/0000-0003-4885-1157","affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University , Boston, MA , USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043562974","display_name":"Kathleen Kiernan Harnden","orcid":"https://orcid.org/0000-0002-8211-708X","observed_orcids":["https://orcid.org/0000-0002-8211-708X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen Harnden","raw_affiliation_strings":["Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071506315","display_name":"Lauren Ann Mauro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren Mauro","raw_affiliation_strings":["Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066037507","display_name":"Angela Pennisi","orcid":"https://orcid.org/0000-0002-3706-3780","observed_orcids":["https://orcid.org/0000-0002-3706-3780"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Pennisi","raw_affiliation_strings":["Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Oncology Program, Inova Schar Cancer Institute , Fairfax, VA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045933995","display_name":"Melissa Armitage","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Armitage","raw_affiliation_strings":["Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Soliman","raw_affiliation_strings":["Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA","Experimental Therapeutics Program, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Experimental Therapeutics Program, H. Lee Moffitt Cancer Center & Research Institute , Tampa, FL , USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034972183"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":3494,"currency":"USD","value_usd":3494},"apc_paid":{"value":3494,"currency":"USD","value_usd":3494},"fwci":3.0324,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.93822478,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"27","issue":"8","first_page":"637","last_page":"645"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8040000200271606},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.8090000152587891},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.996999979019165},{"id":"https://openalex.org/keywords/institutional-protocols","display_name":"institutional protocols","score":0.5289999842643738},{"id":"https://openalex.org/keywords/real-world-clinical-practice","display_name":"real-world clinical practice","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8903999924659729},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7865299582481384},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6181707978248596},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5817927718162537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5669736266136169},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.485301673412323},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.4641951322555542},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4325654208660126},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.31951791048049927},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3035576045513153}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012196","descriptor_name":"Review Literature as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/oncolo/oyac107","doi":"https://doi.org/10.1093/oncolo/oyac107","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyac107","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/8/637/45293643/oyac107.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9355822","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9355822","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:35642907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35642907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyac107","doi":"https://doi.org/10.1093/oncolo/oyac107","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyac107","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/8/637/45293643/oyac107.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281908586.pdf","grobid_xml":"https://content.openalex.org/works/W4281908586.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1937858809","https://openalex.org/W1944571622","https://openalex.org/W1974685860","https://openalex.org/W2142688840","https://openalex.org/W2148056339","https://openalex.org/W2159427817","https://openalex.org/W2387397851","https://openalex.org/W2885900087","https://openalex.org/W2917113139","https://openalex.org/W2972661182","https://openalex.org/W2996630100","https://openalex.org/W3094626347","https://openalex.org/W3209633264","https://openalex.org/W4220964921","https://openalex.org/W4389538252","https://openalex.org/W6803255545"],"related_works":["https://openalex.org/W4290993146","https://openalex.org/W4412613439","https://openalex.org/W3183416111","https://openalex.org/W4377087871","https://openalex.org/W4385659305","https://openalex.org/W7116944098","https://openalex.org/W4416987515","https://openalex.org/W4391694031","https://openalex.org/W4393098912","https://openalex.org/W7161949574"],"abstract_inverted_index":{"The":[0],"treatment":[1],"of":[2,18,41,95,111,115,117,124,133,168,184,193,206],"metastatic":[3,66,82],"breast":[4,69],"cancer":[5,70],"(mBC)":[6],"has":[7],"evolved":[8],"significantly":[9],"in":[10,56,59,80,98],"the":[11,16,39,45,57,81,85,166,204],"past":[12],"several":[13],"years":[14],"with":[15,28,64,102,105,175,200],"approval":[17],"new":[19,36,135],"targeted":[20],"agents.":[21],"Trastuzumab":[22],"deruxtecan":[23],"(T-DXd),":[24],"an":[25],"antibody-drug":[26],"conjugate":[27],"a":[29,35,106],"topoisomerase":[30],"I":[31],"inhibitor":[32],"payload,":[33],"is":[34],"addition":[37,128],"to":[38,129,141],"class":[40],"therapies":[42],"that":[43],"target":[44],"human":[46],"epidermal":[47],"growth":[48],"factor":[49],"2":[50,74],"(HER2)":[51],"receptor.":[52],"T-DXd":[53,91,150,201],"was":[54],"approved":[55],"US":[58],"December":[60],"2019":[61],"for":[62],"patients":[63,101,174],"HER2-positive":[65,103],"or":[67,75],"unresectable":[68],"who":[71,172,210],"have":[72,211],"received":[73],"more":[76,152],"prior":[77],"anti-HER2-based":[78],"regimens":[79],"setting.":[83],"In":[84,127],"DESTINY-Breast01":[86],"phase":[87],"II":[88],"trial":[89],"(NCT03248492),":[90],"demonstrated":[92],"high":[93],"rates":[94],"durable":[96],"responses":[97],"heavily":[99],"pretreated":[100],"mBC,":[104],"confirmed":[107],"objective":[108],"response":[109,116],"rate":[110],"62%,":[112],"median":[113,121],"duration":[114],"18.2":[118],"months,":[119],"and":[120,144,165,182,186,195],"progression-free":[122],"survival":[123],"19.4":[125],"months.":[126],"efficacy,":[130],"successful":[131],"implementation":[132],"any":[134],"anticancer":[136],"therapy":[137],"includes":[138],"learning":[139],"how":[140],"prevent,":[142],"monitor,":[143],"manage":[145],"treatment-related":[146],"adverse":[147,197],"events.":[148],"As":[149],"becomes":[151],"widely":[153],"used,":[154],"information":[155],"can":[156],"be":[157],"gained":[158],"from":[159,203],"real-world":[160],"clinical":[161],"practices,":[162],"institutional":[163],"approaches,":[164],"collaboration":[167],"multidisciplinary":[169],"oncology":[170],"teams":[171],"treat":[173],"T-DXd.":[176,214],"This":[177],"article":[178],"reviews":[179],"practical":[180],"insights":[181],"management":[183],"nausea":[185],"vomiting,":[187],"neutropenia,":[188],"interstitial":[189],"lung":[190],"disease,":[191],"risk":[192],"cardiotoxicity,":[194],"other":[196],"events":[198],"associated":[199],"administration":[202],"perspective":[205],"health":[207],"care":[208],"providers":[209],"experience":[212],"utilizing":[213]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-06-13T00:00:00"}